D/ChAd63-CAT (US Army Medical Research and Materiel Command)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameD/ChAd63-CAT (US Army Medical Research and Materiel Command)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMalaria

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesU.S. Army Medical Research And Materiel Command

China Registration ClassN/A

Develop Information

Active CompaniesU.S. Army Medical Research And Materiel Command

Inactive CompaniesN/A

Active IndicationsMalaria

Inactive IndicationsN/A

Other Information

ATC CodeN/A